Corticobasal Degeneration
31
9
12
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (31)
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
Digital Measurements of Motor and Voice Functions in FTD
Neurological Soft Signs in Neurodegenerative Dementias
Community Outreach for Palliative Engagement -- Parkinson Disease
A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes
The CurePSP Genetics Program
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
Imaging Studies in Corticobasal Syndrome
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
Gait Analysis in Neurological Disease
4 Repeat Tauopathy Neuroimaging Initiative
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
The Swedish BioFINDER 2 Study
NYSCF Scientific Discovery Biobank
The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Sociodemographic Factors and Criminal Behaviour Preceding Neurodegenerative Disease - Retrospective Register Study
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study